Howe & Rusling’s Xylem XYL Stock Holding History

Howe & Rusling’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-530	Closed	-$26K	–	1067
2016 Q4	$26K	Hold	530	–	–	0.01%	330
2016 Q3	$28K	Buy	+530	New	+$26K	0.01%	323

Other funds holding XYL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Howe & Rusling's XYL Position: Q1 2017 in Review

Howe & Rusling sold out of Xylem (XYL) in Q1 2017, closing a stake of 530 shares — an estimated $26K sold.

Howe & Rusling first reported a position in XYL in Q3 2016 and held it in 2 quarters. The position peaked at $28K in Q3 2016. 546 funds tracked by Wall St. Rank hold XYL as of Q1 2017.

Howe & Rusling reported no remaining Xylem position as of Q1 2017 after selling out during the quarter.
Howe & Rusling sold 530 Xylem shares in Q1 2017, an estimated $26K.
Howe & Rusling first reported a position in Xylem in Q3 2016 and held it in 2 quarters.
Howe & Rusling's Xylem position peaked at $28K in Q3 2016.
546 funds tracked by Wall St. Rank held Xylem as of Q1 2017.

Based on Howe & Rusling's 13F filing for Q1 2017, filed 18 Apr 2017.